Surveillance cultures in healthcare-associated pneumonia: Sense or nonsense?

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 3, 2014, Pages 259-271

  Scholte, Johannes B J ^a   Van Mook, Walther N K A ^a   Linssen, Catharina F M ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

Author keywords

guidelines; healthcare associated pneumonia; ICUs; multidrug resistant; surveillance cultures; ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIGESTIVE TRACT DECONTAMINATION; DISEASE SURVEILLANCE; GRAM NEGATIVE BACTERIUM; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; POPULATION; PREDICTIVE VALUE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; CROSS INFECTION; FEMALE; ISOLATION AND PURIFICATION; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINE; PROCEDURES; SENTINEL SURVEILLANCE; STANDARDS;

CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFECTION CONTROL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; SENTINEL SURVEILLANCE;

EID: 84897579966     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000044     Document Type: Review

References (91)

1. Attridge RT. Healthcare-associated pneumonia: refining the HCAP criteria. In: Pharmacotherapy Conference; November 20, 2009. San Antonio, TX: University of Texas Health Sciences Center; 2009. pp. 1-25.
2. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393-1399.
3. Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis 2013; 13:561.
4. Polverino E, Torres A, Menendez R, et al. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax 2013; 68:1007-1014.
5. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
6. Micek ST, Kollef KE, Reichley RM, et al. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-3573.
7. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culturepositive pneumonia. Chest 2005; 128:3854-3862.
8. Giannella M, Pinilla B, Capdevila JA, et al. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect 2012; 18:786-794.
9. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011; 17:1659-1665.
10. Chalmers JD, Rother C, Salih W, Ewig S. Healthcare associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2013; 58:330-339.
11. Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, healthcare-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150:19-26.
12. van Duijn PJ, Dautzenberg MJ, Oostdijk EA. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care 2011; 17:658-665.
13. Gastmeier P, Geffers C, Brandt C, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006; 64:16-22.
14. Carlet J, Astagneau P, Brun-Buisson C, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009; 30:737-745.
15. Gaynes R, Richards C, Edwards J, et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 2001; 7: 295-298.
16. Benet T, Allaouchiche B, Argaud L, Vanhems P. Impact of surveillance of hospital-acquired infections on the incidence of ventilator-associated pneumonia in intensive care units: a quasi-experimental study. Crit Care 2012; 16:R161.
17. Gil-Perotin S, Ramirez P, Marti V, et al. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 2012; 16:R93.
18. Bonten MJ, Bergmans DC, Ambergen AW, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996; 154:1339-1346.
19. Cardenosa Cendrero JA, Sole-Violan J, Bordes Benitez A, et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 1999; 116:462-470.
20. Boots RJ, Phillips GE, George N, Faoagali JL. Surveillance culture utility and safety using low-volume blind bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Respirology 2008; 13:87-96.
21. Brusselaers N, Labeau S, Vogelaers D, Blot S. Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 2013; 39:365-375.
22. A'Court CH, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using nondirected bronchial lavage and quantitative culture. Q J Med 1993; 86:635-648.
23. de Latorre FJ, Pont T, Ferrer A, et al. Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med 1995; 152:1028-1033.
24. Delclaux C, Roupie E, Blot F, et al. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med 1997; 156:1092-1098.
25. Flanagan PG, Findlay GP, Magee JT, et al. The diagnosis of ventilatorassociated pneumonia using nonbronchoscopic, nondirected lung lavages. Intensive Care Med 2000; 26:20-30.
26. Hayon J, Figliolini C, Combes A, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:41-46.
27. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003; 31:1964-1970.
28. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BALconfirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005; 127:589-597.
29. Depuydt P, Benoit D, Vogelaers D, et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 2006; 32:1773-1781.
30. Depuydt PO, Blot SI, Benoit DD, et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 2006; 34:653-659.
31. Bagnulo HGM, Galiana A, Bertulo M, Pedreira W. Are routine endotracheal aspirates predictive of etiology of ventilator-associated pneumonia? Crit Care 2007; 11 (Suppl 2):87.
32. Malacarne P, Corini M, Maremmani P, et al. Diagnostic characteristics of routine surveillance cultures of endotracheal aspirate samples in cases of lateonset ventilator-associated pneumonia due to Acinetobacter baumannii. Infect Control Hosp Epidemiol 2007; 28:867-869.
33. Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008; 34:675-682.
34. Nair S, Sen N, Peter JV, et al. Role of quantitative endotracheal aspirate and cultures as a surveillance and diagnostic tool for ventilator associated pneumonia: a pilot study. Indian J Med Sci 2008; 62:304-313.
35. Jung B, Sebbane M, Chanques G, et al. Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 2009; 35:101-107.
36. Pirracchio R, Mateo J, Raskine L, et al. Can bacteriological upper airway samples obtained at intensive care unit admission guide empiric antibiotherapy for ventilator-associated pneumonia? Crit Care Med 2009; 37:2559-2563.
37. Lampati L, Maggioni E, Langer M, et al. Can routine surveillance samples from tracheal aspirate predict bacterial flora in cases of ventilator-associated pneumonia? Minerva Anestesiol 2009; 75:555-562.
38. Joseph NM, Sistla S, Dutta TK, et al. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures. Int J Infect Dis 2010; 14:e723-e729.
39. Gursel G, Aydogdu M, Nadir Ozis T, Tasyurek S. Comparison of the value of initial and serial endotracheal aspirate surveillance cultures in predicting the causative pathogen of ventilator-associated pneumonia. Scand J Infect Dis 2010; 42:341-346.
40. Brusselaers N, Logie D, Vogelaers D, et al. Burns, inhalation injury and ventilator-associated pneumonia: value of routine surveillance cultures. Burns 2012; 38:364-370.
41. Chan JD, Dellit TH, Choudhuri JA, et al. Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med 2012; 40:1437-1442.
42. Luna CM, Sarquis S, Niederman M, et al. Is an endotracheal routine culturesbased strategy the best way to prescribe antibiotics in ventilator-associated pneumonia? Chest 2013; 144:63-71.
43. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003; 37:921-928.
44. Huang SS, Rifas-Shiman SL, Pottinger JM, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 2007; 195:339-346.
45. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillinresistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195:330-338.
46. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008; 46:1717-1725.
47. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148:409-418.
48. Stano P, Avolio M, De Rosa R, et al. An antibiotic care bundle approach based on results of rapid molecular screening for nasal carriage of methicillinresistant Staphylococcus aureus in the intensive care unit. In Vivo 2012; 26:469-472.
49. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364:1407-1418.
50. Bertrand X, Thouverez M, Talon D, et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 2001; 27:1263-1268.
51. Blot S, Depuydt P, Vogelaers D, et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibioticresistant Gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 2005; 26:575-579.
52. Reddy P, Malczynski M, Obias A, et al. Screening for extended-spectrum betalactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007; 45:846-852.
53. Papadomichelakis E, Kontopidou F, Antoniadou A, et al. Screening for resistant Gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008; 34:2169-2175.
54. Baba H, Nimmo GR, Allworth AM, et al. The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit. Eur J Clin Microbiol Infect Dis 2011; 30:739-744.
55. Galoisy-Guibal L, Soubirou JL, Desjeux G, et al. Screening for multidrugresistant bacteria as a predictive test for subsequent onset of nosocomial infection. Infect Control Hosp Epidemiol 2006; 27:1233-1241.
56. Vandewoude KH, Blot SI, Depuydt P, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006; 10:R31.
57. Sreeramoju PV, Garcia-Houchins S, Bova J, et al. Correlation between respiratory colonization with Gram-negative bacteria and development of Gram-negative bacterial infection after cardiac surgery. Infect Control Hosp Epidemiol 2008; 29:546-548.
58. Novosel TJ, Hodge LA, Weireter LJ, et al. Ventilator-associated pneumonia: depends on your definition. Am Surg 2012; 78:851-854.
59. Worster A, Carpenter C. Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias. CJEM 2008; 10:174-175.
60. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. Ann Pharmacother 2009; 43: 28-35.
61. Aydogdu M, Gursel G, Hizel K, Ozis TN. Comparison of the serial surveillance with quantitative and nonquantitative tracheal aspirate in predicting ventilatorassociated pneumonia etiology in patients receiving antibiotic therapy. Minerva Anestesiol 2010; 76:600-608.
62. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52:113-122.
63. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
64. Jernigan JA, Titus MG, Groschel DH, et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496-504.
65. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005; 33:309-313.
66. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18:461-466.
67. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
68. Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005; 11:457-465.
69. de Smet AM, Hopmans TE, Minderhoud AL, et al. Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit. Intensive Care Med 2009; 35:1609-1613.
70. Van de Voort PHJ, van Saene HKF (editors). Selective digestive tract decontamination in intensive care medicine: a practical guide to controlling infection. 1 ed. Springer; 2008.
71. Viviani M, Van Saene HK, Pisa F, et al. The role of admission surveillance cultures in patients requiring prolonged mechanical ventilation in the intensive care unit. Anaesth Intensive Care 2010; 38:325-335.
72. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in nonepidemic situations. Infect Control Hosp Epidemiol 2004; 25:838-841.
73. Muto CA, Giannetta ET, Durbin LJ, et al. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23:429-435.
74. Nyman JA, Lees CH, Bockstedt LA, et al. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals. Am J Infect Control 2011; 39:27-34.
75. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-132.
76. Robotham JV, Graves N, Cookson BD, et al. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 2011; 343:d5694.
77. Olchanski N, Mathews C, Fusfeld L, Jarvis W. Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin- resistant Staphylococcus aureus screening programs in US hospitals. Infect Control Hosp Epidemiol 2011; 32:250-257.
78. Masterton R, Craven D, Rello J, et al. Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development. J Antimicrob Chemother 2007; 60:206-213.
79. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2):S27-72.
80. Memish ZA, Arabi YM, Ahmed QA, et al. Executive summary of the Gulf Cooperation Council practice guidelines for the management of community-acquired pneumonia. J Chemother 2007; 19 (Suppl 1): 7-11.
81. Feldman C, Brink AJ, Richards GA, et al. Management of community-acquired pneumonia in adults. S Afr Med J 2007; 97:1296-1306.
82. Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008; 23:126-137.
83. Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. J Crit Care 2008; 23:138-147.
84. Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008; 62:5-34.
85. Mosier MJ, Pham TN. American Burn Association Practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2009; 30:910-928.
86. Correa Rde A, Lundgren FL, Pereira-Silva JL, et al. Brazilian guidelines for community-acquired pneumonia in immunocompetent adults: 2009. J Bras Pneumol 2009; 35:574-601.
87. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl 3):iii1-iii55.
88. Menendez R, Torres A, Aspa J, et al. Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol 2010; 46:543-558.
89. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections: full version. Clin Microbiol Infect 2011; 17 (Suppl 6):E1-E59.
90. Wiersinga WJ, Bonten MJ, Boersma WG, et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 2012; 70:90-101.
91. Spindler C, Stralin K, Eriksson L, et al. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults: Swedish Society of Infectious Diseases 2012. Scand J Infect Dis 2012; 44:885-902.